| OA + MBP | MBP | p value |
---|---|---|---|
Number | 124 | 124 | Â |
Age | 60.81 ± 12.00 | 60.04 ± 11.25 | 0.605 |
Gender (male/female) | 77/47 | 66/58 | 0.157 |
BMI | 22.95 ± 3.35 | 23.42 ± 3.40 | 0.268 |
Approach (open/lap) | 6/118 | 12/112 | 0.142 |
Surgical time (min) | 189.67 ± 63.71 | 199.86 ± 60.77 | 0.200 |
ASA (1/2/3/4) | 68/48/8 | 69/37/18 | 0.071 |
Stage (1/2/3/4) | 22/47/34/21 | 19/48/38/19 | 0.907 |
Neoadjuvant chemotherapy | 4 | 6 | 0.749 |
Albumin | 40.07 ± 3.88 | 40.99 ± 5.29 | 0.12 |
Postoperative LOS (day) | 9.79 ± 4.68 | 9.89 ± 6.21 | 0.881 |
Expenses (kRMB) | 54.25 ± 14.25 | 67.67 ± 34.68 | < 0.05 |
Anastomotic fistula | 2 | 5 | 0.446 |
SSIs | 13 (100%) | 31 (100%) | 0.004 |
 Superficial | 7 (53.8%) | 17 (54.9%) | 0.032 |
 Deep | 1 (7.7%) | 5 (16.1%) | 0.213 |
 Space | 5 (38.5%) | 9 (29.0%) | 0.271 |
Ileus | 8 | 6 | 0.582 |
Urinary infection | 2 | 1 | 1 |
CDI | 5 | 3 | 0.722 |
Pulmonary infection | 3 | 2 | 1 |
Readmission | 3 | 1 | 0.622 |